Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Intelsius Introduces Reusable Courier Transit Case

Published: Monday, July 29, 2013
Last Updated: Monday, July 29, 2013
Bookmark and Share
BioCarrier™ - Designed for local courier routes and multiple site sample collections.

Intelsius has introduced the first of its kind range of solutions, BioCarrier™, specifically designed for local courier routes and multiple site sample collections.

“Intelsius is proudly introducing the BioCarrier line to the life science leaders and industry professionals at the largest and most well attended clinical trial conference of the year,” said David Walsh, CEO, Intelsius. “This is a regulatory compliant solution rather than couriers carrying samples or medicines from clinic to clinic or pharmacy to pharmacy in picnic coolers.”

BioCarrier cases are designed to provide regular route, multiple site sample collection and “home visit” temperature-sensitive injectable drug protection.

The rugged polymer outer with the expanded polypropylene (EPP) insulated liner maintains payload integrity at 2-8 degrees Celsius for 12 hours plus or when using dry ice up to 18 hours.

All three sizes are regulatory compliant with pre-printed UN3373 labels for the shipment of Category B biological samples.

“The rigid, durable, regulatory compliant marked outer cases feature a clasp closure allowing the lid to be secured and the cases to be stacked and locked together, making them an Intelsius exclusive,” said Alex Roskoss, Intelsius European head of technical services.

“These cases were ergonomically designed specifically for couriers to enable safe, comfortable, compliant transportation around the corner or across town,” Roskoss added. Its discreet design keeps the contents confidential.

“Keeping people safe while samples or medicines are being transported around town is the primary reason for creating the BioCarrier line of products,” said Walsh.

Intelsius serves a wide range of organizations, including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries to major laboratories.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Find U.S. Breast Milk is Glyphosate Free
Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother’s breast milk.
Peering into the Vapors
Research suggests that e-cigarettes are much less harmful than previous studies have indicated.
New Technique for Mining Health-conferring Soy Compounds
A new procedure devised by U.S. Department of Agriculture (USDA) scientists to extract lunasin from soybean seeds could expedite further studies of this peptide for its cancer-fighting potential and other health benefits.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!